Badger Meter vs Vontier
BMI and VNT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BMI and VNT compare
Vontier is the larger company, worth 1.3 times as much as Badger Meter ($5.8B against $4.4B).
Badger Meter grew revenue faster over the last twelve months (10.9% versus 0.29% for Vontier).
Both pay dividends: Badger Meter yields 1.1% and Vontier 0.23%.
Badger Meter scores higher on the StockData Score (25 against 11 for Vontier), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BMI | VNT |
|---|---|---|
| Size and price | ||
| Market cap | $4.4B | $5.8B |
| Share price | $153.59 | $43.18 |
| Change, 1 year | −17.2% | 15.7% |
| Change, 5 years | 41.7% | 27.2% |
| Beta (5Y) | 0.82 | 1.06 |
| Employees | 2,477 | 7,800 |
| StockData Score | ||
| Total score | 25 (better) | 11 |
| Valuation score | 5 (better) | 2 |
| Growth score | 4 (better) | 1 |
| Performance score | 6 (better) | 1 |
| Health score | 6 (better) | 4 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 32.1× | – |
| P/S | 4.8× | 1.9× (better) |
| P/B | 6.7× | 4.8× (better) |
| EV/EBITDA | 23.5× | 11.7× (better) |
| P/FCF | 25.9× | 14.0× (better) |
| PEG | 1.13 | – |
| FCF yield | 3.9% | 7.1% (better) |
| Fair value | $194.99 | $55.52 |
| Margin of safety | 21.2% | 22.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 10.9% (better) | 0.29% |
| Revenue growth, 5Y average | 16.6% (better) | 2.6% |
| Net income growth (TTM) | 13.4% | – |
| EPS growth (TTM) | 13.2% | – |
| EPS growth, 5Y average | 23.2% (better) | 6.4% |
| Profitability | ||
| Gross margin | 41.7% | – |
| Operating margin | 20.0% (better) | 19.4% |
| Net margin | 15.5% | – |
| FCF margin | 18.5% (better) | 13.6% |
| Return on equity | 22.5% | – |
| Return on invested capital | 30.8% (better) | 15.8% |
| Financial health | ||
| Debt / equity | 0.00 | 1.57 (better) |
| Net debt / EBITDA | – | 2.58 |
| Current ratio | 2.48 (better) | 1.23 |
| Altman Z-score | 11.93 (better) | 3.25 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Dividend yield | 1.1% (better) | 0.23% |
| Payout ratio | 30.7% | – |
| Years of dividend growth | 11 (better) | 0 |
| Dividend growth, 5Y average | 16.2% | – |
| Buyback yield | 0.34% | 6.9% (better) |
| Shareholder yield | 1.4% | 7.2% (better) |
| Ownership | ||
| Held by institutions | 114% | 110% |
| Held by insiders | 0.68% | 0.79% |
| Insider net buying, 12 months | $1.5M (better) | −$688K |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 13.5% | 9.0% |
Go deeper
- BMI stock overview
- BMI income statement
- BMI valuation and score
- VNT stock overview
- VNT income statement
- VNT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.